tirzepatide surmount 3 for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial SURMOUNT-5: Tirzepatide shows superior weight

My personal opinion

In some cases, your insurance provider may also require you to do step therapy which is a requirement for you to try and fail treatment with a different and less expensive medication first

Although the adjunctive use of such antithrombotic therapies can potentially further reduce the risk of ischaemic events, these agents are also inevitably associated with an increased risk of bleeding

The medical community today agrees that obesity is a chronic disease, it is a serious condition that increases the risk of premature death and can lead to other serious health issues such as heart disease, stroke and diabetes," said Chiquita Brooks-LaSure, administrator for the Centers for Medicare and Medicaid Services, in a call with reporters

Doctors usually monitor routine blood tests to ensure treatment remains safe and well tolerated

Common side effects of tirzepatide include nausea, vomiting, diarrhea, constipation, abdominal pain, decreased appetite, injection site reactions (such as redness, swelling, or pain), fatigue, and gastrointestinal issues like heartburn, gas, and bloating